BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP
Follow-ons only
Follow-ons only: first sale Dec 2020, per Form D (fund age approximates vintage)
- Vintage
- 2020
- Fund size
- $204.5M to $350M (Form D)
- Stages
- Not stated
- Sectors
- Medical devices
- Regions
- Not stated
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$2.04M to $5.83M (estimated from fund size)
Estimated from Form D: $204.5M sold of a $350M target
03 · Who to approach
Named on this fund's Form D
- Marc Goldberg, Managing Director of the Issuer's General Partner.
- Jonathan P. Gertler, MANAGING DIRECTOR
- James Lousararian, Managing Director of the Issuer's General Partner.
- Jeffrey Barnes, Managing Director of the Issuer's General Partner.
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideInvests in MedTech companies at early and growth stages, providing capital, expertise, and support to portfolio companies.
The global MedTech market presents a unique and under-served opportunity for companies and their investors.
https://www.bioventuresinvestors.com/investment-strategy
06 · Sources
Last verified: Oct 25, 2026